FDA Approved: ARIPIPRAZOLE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for aripiprazole from Bionpharma Inc., enabling the generic product to be marketed in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)